Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2022-12-30 00:00:00 ET · period of report 2022-12-28 · accession 0001415889-22-013102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-30 | 2022-12-28+ | FENC | Andrade Robert | CFO | S - Sale | $9.60 | -22.0K | 160.7K | -12% | -$211.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2022-12-30 | S | D | 5,500 | $9.61 | 149,721 | D | — | — | (F3) Represents shares sold pursuant to a 10b5-1 plan on December 30, 2022. |
| 2 | Common | Common shares | 2022-12-29 | S | D | 5,500 | $9.57 | 155,221 | D | — | — | (F2) Represents shares sold pursuant to a 10b5-1 plan on December 29, 2022. |
| 3 | Common | Common shares | 2022-12-28 | S | D | 11,000 | $9.61 | 160,721 | D | — | — | (F1) Represents shares sold pursuant to a 10b5-1 plan on December 28, 2022. |